Number | Cited Articles |
1 |
Renáta Bor, Anna Fábián, Klaudia Farkas, Tamás Molnár, Zoltán Szepes. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn’s disease – review of pathomechanism and existing clinical data. Expert Opinion on Biological Therapy 2018; 18(7): 737 doi: 10.1080/14712598.2018.1492543
|
2 |
Mariano Garcia‐Arranz, Damián Garcia‐Olmo, María Dolores Herreros, José Gracia‐Solana, Héctor Guadalajara, Fernando Portilla, Jorge Baixauli, Jacinto Garcia‐Garcia, José Manuel Ramirez, Fermín Sanchez‐Guijo, Felipe Prosper. Autologous adipose‐derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long‐term follow‐up. STEM CELLS Translational Medicine 2020; 9(3): 295 doi: 10.1002/sctm.19-0271
|
3 |
Richard Taubert, Katharina Luise Hupa-Breier, Elmar Jaeckel, Michael P. Manns. Novel therapeutic targets in autoimmune hepatitis. Journal of Autoimmunity 2018; 95: 34 doi: 10.1016/j.jaut.2018.10.022
|
4 |
Judith Gronbach, Tayyab Shahzad, Sarah Radajewski, Cho-Ming Chao, Saverio Bellusci, Rory E. Morty, Tobias Reicherzer, Harald Ehrhardt. The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant. Stem Cells International 2018; 2018: 1 doi: 10.1155/2018/9652897
|
5 |
Erica P Turse, Francis E Dailey, Maliha Naseer, Edward K Partyka, Veysel Tahan. One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy. World Journal of Clinical Cases 2018; 6(12): 493-500 doi: 10.12998/wjcc.v6.i12.493
|
6 |
Jian Niu, Wang Yue, Zhu Le-Le, Liu Bin, Xin Hu. Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex. Oncotarget 2017; 8(59): 99784 doi: 10.18632/oncotarget.21549
|
7 |
Mercedes Lopez-Santalla, Raquel Fernandez-Perez, Marina I. Garin. Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications. Cells 2020; 9(8): 1852 doi: 10.3390/cells9081852
|